3 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Terminated 3 |
Follow Vision Disorders: new trials by email Literature Review of Vision Disorders trials Research Report on Vision Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Vascular Endothelial Growth Factor (VEGF) Levels in Retinal Vein Occlusion (RVO) During Anti-VEGF Treatment Aflibercept Ophthalmic - Retinal Vein Occlusion | Phase 4 | Terminated | Wake Forest University Health Sciences | 17 | 2021-10-06 | 2025-02-24 |
| PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) Diagnostic procedures - Anterior Ischemic Optic Neuropathy | Phase 4 | Terminated | Bayer | 10 | 2009-07-13 | 2019-01-23 |
| Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity ACULAR, REFRESH TEARS, placebo - Retinopathy of Prematurity, Retinal Detachment | Phase 4 | Terminated | University of South Alabama | 83 | 2005-11-01 | 2020-12-08 |
Blindness (2) · Erectile Dysfunction (1) · Optic Nerve Diseases (1) · Optic Neuropathy, Ischemic (1) · Premature Birth (1) · Retinal Detachment (1) · Retinal Vein Occlusion (1) · Retinopathy of Prematurity (1)
Eye Diseases (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Pathological Conditions, Signs and Symptoms (3) · Sensation Disorders (3) · Signs and Symptoms (3) · Cardiovascular Diseases (2) · Retinal Diseases (2) · Urogenital Diseases (2) · Vascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Cranial Nerve Diseases (1) · Embolism and Thrombosis (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1)
Ketorolac (1) · Ketorolac Tromethamine (1) · aflibercept (1)
Bayer (1) · University of South Alabama (1) · Wake Forest University Health Sciences (1)
United States (3) · Australia (1) · Canada (1)
Fabien G Eyal, M.D. (1) · Mark Nelson, MD (1)